SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Corixa [CRXA] - cancer vaccines -- Ignore unavailable to you. Want to Upgrade?


To: SemiBull who wrote (119)1/8/2002 10:41:34 PM
From: Vector1  Read Replies (1) | Respond to of 222
 
Semi, good news for CRXA. The stock was down today on IDPH getting a complete review letter from the FDA for Zevalin.
The Complete Review Letter confirms that the company's investigational agentZevalin is approvable pending resolution of certain manufacturing complianceissues at the company's fill/finish provider, and that no additional clinical data are required. In addition, the letter stated that all labeling issues havebeen resolved.
V1